Skip to main content
Erschienen in: European Radiology 5/2017

05.09.2016 | Gastrointestinal

Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer

verfasst von: Jing Yu, Qing Xu, Dong-Ya Huang, Jia-Cheng Song, Yan Li, Lu-Lu Xu, Hai-Bin Shi

Erschienen in: European Radiology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To explore the correlations between DCE-MRI quantitative parameters and synchronous distant metastasis and the clinicopathological factors in rectal cancers.

Methods

Sixty-three patients with rectal cancer (synchronous distant metastasis, n = 31; non-metastasis, n = 32) were enrolled in this study. Student’s t test and ANOVA were used to compare DCE-MRI parameters (K trans , K ep and V e ). The receiver operating characteristic (ROC) analysis was used to find the reasonable threshold of DCE-MRI parameters to differentiate lesions with synchronous distant metastasis from those without metastasis.

Results

The K trans , K ep , and V e value were significantly higher in the lesions with distant metastasis than in the lesions without distant metastasis (0.536 ± 0.242 vs. 0.299 ± 0.118 min-1, p < 0.001; 1.598 ± 0.477 vs. 1.341 ± 0.390 min-1, p = 0.022; and 0.324 ± 0.173 vs. 0.249 ± 0.091, p = 0.034; respectively). The K trans showed the highest AUCs of 0.788 (p < 0.001), with sensitivity of 61.29 % and specificity of 87.5 %, respectively.

Conclusions

DCE-MRI parameters may represent a prognostic indicator for synchronous distant metastases in patients with rectal cancer.

Key Points

The K trans , K ep and V e values correlated with synchronous distant metastasis.
Higher K trans , K ep and V e values were noted among patients with metastasis.
DCE-MRI parameters might represent a prognostic indicator for synchronous distant metastases.
Literatur
1.
Zurück zum Zitat Engelen SM, Maas M, Lahaye MJ, Leijtens JW, van Berlo CL, Jansen RL et al (2013) Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur J Cancer 49:2311–2320CrossRefPubMed Engelen SM, Maas M, Lahaye MJ, Leijtens JW, van Berlo CL, Jansen RL et al (2013) Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge. Eur J Cancer 49:2311–2320CrossRefPubMed
2.
Zurück zum Zitat Meguerditchian AN, Bairati I, Lagace R, Harel F, Kibrite A (2005) Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg 189:707–713CrossRefPubMed Meguerditchian AN, Bairati I, Lagace R, Harel F, Kibrite A (2005) Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg 189:707–713CrossRefPubMed
3.
Zurück zum Zitat Hong HS, Kim SH, Park HJ, Park MS, Kim KW, Kim WH et al (2013) Correlations of dynamic contrast-enhanced magnetic resonance imaging with morphologic, angiogenic, and molecular prognostic factors in rectal cancer. Yonsei Med J 54:123–130CrossRefPubMed Hong HS, Kim SH, Park HJ, Park MS, Kim KW, Kim WH et al (2013) Correlations of dynamic contrast-enhanced magnetic resonance imaging with morphologic, angiogenic, and molecular prognostic factors in rectal cancer. Yonsei Med J 54:123–130CrossRefPubMed
4.
Zurück zum Zitat Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G (2009) MRI staging of low rectal cancer. Eur Radiol 19:643–650CrossRefPubMed Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G (2009) MRI staging of low rectal cancer. Eur Radiol 19:643–650CrossRefPubMed
5.
Zurück zum Zitat Li L, Wang K, Sun X, Wang K, Sun Y, Zhang G et al (2015) Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer. Med Sci Monit 21:376–382CrossRefPubMedPubMedCentral Li L, Wang K, Sun X, Wang K, Sun Y, Zhang G et al (2015) Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer. Med Sci Monit 21:376–382CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Lollert A, Junginger T, Schimanski CC, Biesterfeld S, Gockel I, Duber C et al (2014) Rectal cancer: dynamic contrast-enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression. J Magn Reson Imaging 39:1436–1442CrossRefPubMed Lollert A, Junginger T, Schimanski CC, Biesterfeld S, Gockel I, Duber C et al (2014) Rectal cancer: dynamic contrast-enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression. J Magn Reson Imaging 39:1436–1442CrossRefPubMed
7.
Zurück zum Zitat Padhani AR (2002) Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16:407–422CrossRefPubMed Padhani AR (2002) Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16:407–422CrossRefPubMed
8.
Zurück zum Zitat Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed
9.
Zurück zum Zitat DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed
10.
Zurück zum Zitat Schisterman EF, Perkins NJ, Liu A, Bondell H (2005) Optimal cut-point and its corresponding Youden Index to discriminate individual using pooled blood samples. Epidemiology 16:73–81CrossRefPubMed Schisterman EF, Perkins NJ, Liu A, Bondell H (2005) Optimal cut-point and its corresponding Youden Index to discriminate individual using pooled blood samples. Epidemiology 16:73–81CrossRefPubMed
11.
Zurück zum Zitat Fidler IJ, Ellis LM (1994) The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185–188CrossRefPubMed Fidler IJ, Ellis LM (1994) The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79:185–188CrossRefPubMed
12.
Zurück zum Zitat Koo HR, Cho N, Song IC, Kim H, Chang JM, Yi A et al (2012) Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers. J Magn Reson Imaging 36:145–151CrossRefPubMed Koo HR, Cho N, Song IC, Kim H, Chang JM, Yi A et al (2012) Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers. J Magn Reson Imaging 36:145–151CrossRefPubMed
13.
Zurück zum Zitat Chen J, Qian T, Zhang H, Wei C, Meng F, Yin H (2016) Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model. Magn Reson Imaging 34:177–182CrossRefPubMed Chen J, Qian T, Zhang H, Wei C, Meng F, Yin H (2016) Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model. Magn Reson Imaging 34:177–182CrossRefPubMed
14.
Zurück zum Zitat Yeo DM, Oh SN, Jung CK, Lee MA, Oh ST, Rha SE et al (2015) Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: preliminary results. J Magn Reson Imaging 41:474–480CrossRefPubMed Yeo DM, Oh SN, Jung CK, Lee MA, Oh ST, Rha SE et al (2015) Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: preliminary results. J Magn Reson Imaging 41:474–480CrossRefPubMed
15.
Zurück zum Zitat Gollub MJ, Cao K, Gultekin DH, Kuk D, Gonen M, Sohn M et al (2013) Prognostic aspects of DCE-MRI in recurrent rectal cancer. Eur Radiol 23:3336–3344CrossRefPubMed Gollub MJ, Cao K, Gultekin DH, Kuk D, Gonen M, Sohn M et al (2013) Prognostic aspects of DCE-MRI in recurrent rectal cancer. Eur Radiol 23:3336–3344CrossRefPubMed
17.
Zurück zum Zitat Christofori G, Semb H (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24:73–76CrossRefPubMed Christofori G, Semb H (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24:73–76CrossRefPubMed
18.
Zurück zum Zitat Herzig M, Savarese F, Novatchkova M, Semb H, Christofori G (2007) Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling. Oncogene 26:2290–2298CrossRefPubMed Herzig M, Savarese F, Novatchkova M, Semb H, Christofori G (2007) Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling. Oncogene 26:2290–2298CrossRefPubMed
19.
Zurück zum Zitat Awasthi R, Rathore RK, Soni P, Sahoo P, Awasthi A, Husain N et al (2012) Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers. Neuroradiology 54:205–213CrossRefPubMed Awasthi R, Rathore RK, Soni P, Sahoo P, Awasthi A, Husain N et al (2012) Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers. Neuroradiology 54:205–213CrossRefPubMed
20.
Zurück zum Zitat Jia Z, Geng D, Xie T, Zhang J, Liu Y (2012) Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging. J Clin Neurosci 19:820–823CrossRefPubMed Jia Z, Geng D, Xie T, Zhang J, Liu Y (2012) Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging. J Clin Neurosci 19:820–823CrossRefPubMed
21.
Zurück zum Zitat Huh JW, Kim CH, Lim SW, Kim HR, Kim YJ (2013) Early recurrence in patients undergoing curative surgery for colorectal cancer: is it a predictor for poor overall survival? Int J Colorectal Dis 28:1143–1149CrossRefPubMed Huh JW, Kim CH, Lim SW, Kim HR, Kim YJ (2013) Early recurrence in patients undergoing curative surgery for colorectal cancer: is it a predictor for poor overall survival? Int J Colorectal Dis 28:1143–1149CrossRefPubMed
22.
Zurück zum Zitat Wang L, Zhong XG, Peng YF, Li ZW, Gu J (2014) Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions). Colorectal Dis 16:33–39CrossRefPubMed Wang L, Zhong XG, Peng YF, Li ZW, Gu J (2014) Prognostic value of pretreatment level of carcinoembryonic antigen on tumour downstaging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions). Colorectal Dis 16:33–39CrossRefPubMed
24.
Zurück zum Zitat Davenport MS, Heye T, Dale BM, Horvath JJ, Breault SR, Feuerlein S et al (2013) Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model. J Magn Reson Imaging 38:329–335CrossRefPubMed Davenport MS, Heye T, Dale BM, Horvath JJ, Breault SR, Feuerlein S et al (2013) Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model. J Magn Reson Imaging 38:329–335CrossRefPubMed
25.
Zurück zum Zitat Sohn B, Lim JS, Kim H, Myoung S, Choi J, Kim NK et al (2015) MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol 25:1347–1355CrossRefPubMed Sohn B, Lim JS, Kim H, Myoung S, Choi J, Kim NK et al (2015) MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol 25:1347–1355CrossRefPubMed
26.
Zurück zum Zitat Kim YC, Kim JK, Kim MJ, Lee JH, Kim YB, Shin SJ (2016) Feasibility of mesorectal vascular invasion in predicting early distant metastasis in patients with stage T3 rectal cancer based on rectal MRI. Eur Radiol 26:297–305CrossRefPubMed Kim YC, Kim JK, Kim MJ, Lee JH, Kim YB, Shin SJ (2016) Feasibility of mesorectal vascular invasion in predicting early distant metastasis in patients with stage T3 rectal cancer based on rectal MRI. Eur Radiol 26:297–305CrossRefPubMed
27.
Zurück zum Zitat Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P et al (2012) Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer 118:628–638CrossRefPubMed Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P et al (2012) Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer 118:628–638CrossRefPubMed
28.
Zurück zum Zitat Gunther K, Dworak O, Remke S, Pfluger R, Merkel S, Hohenberger W et al (2002) Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 103:68–78CrossRefPubMed Gunther K, Dworak O, Remke S, Pfluger R, Merkel S, Hohenberger W et al (2002) Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 103:68–78CrossRefPubMed
29.
Zurück zum Zitat Lim SB, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC (2010) Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum 53:377–384CrossRefPubMed Lim SB, Yu CS, Jang SJ, Kim TW, Kim JH, Kim JC (2010) Prognostic significance of lymphovascular invasion in sporadic colorectal cancer. Dis Colon Rectum 53:377–384CrossRefPubMed
30.
Zurück zum Zitat Glynne-Jones R, Anyamene N, Moran B, Harrison M (2012) Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation? Ann Oncol 23:2517–2526CrossRefPubMed Glynne-Jones R, Anyamene N, Moran B, Harrison M (2012) Neoadjuvant chemotherapy in MRI-staged high-risk rectal cancer in addition to or as an alternative to preoperative chemoradiation? Ann Oncol 23:2517–2526CrossRefPubMed
31.
Zurück zum Zitat Chua YJ, Barbachano Y, Cunningham D, Oates JR, Brown G, Wotherspoon A et al (2010) Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 11:241–248CrossRefPubMed Chua YJ, Barbachano Y, Cunningham D, Oates JR, Brown G, Wotherspoon A et al (2010) Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial. Lancet Oncol 11:241–248CrossRefPubMed
32.
Zurück zum Zitat Scharitzer M, Ba-Ssalamah A, Ringl H, Kolblinger C, Grunberger T, Weber M et al (2013) Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol 23:2187–2196CrossRefPubMed Scharitzer M, Ba-Ssalamah A, Ringl H, Kolblinger C, Grunberger T, Weber M et al (2013) Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Eur Radiol 23:2187–2196CrossRefPubMed
Metadaten
Titel
Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer
verfasst von
Jing Yu
Qing Xu
Dong-Ya Huang
Jia-Cheng Song
Yan Li
Lu-Lu Xu
Hai-Bin Shi
Publikationsdatum
05.09.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2017
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4532-y

Weitere Artikel der Ausgabe 5/2017

European Radiology 5/2017 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.